CYP26A1 Antibodies

Santa Cruz Biotechnology features a diverse variety of CYP26A1 monoclonal antibodies for research focused on understanding this important enzyme. CYP26A1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP26A1 is a key enzyme involved in the metabolism of retinoic acid, a derivative of vitamin A that plays a crucial role in cellular differentiation, growth, and embryonic development. By regulating retinoic acid levels, CYP26A1 is essential for maintaining proper physiological functions and preventing developmental disorders. Understanding CYP26A1 activity can provide insights into various diseases, including cancer and congenital malformations. Researchers can utilize CYP26A1 monoclonal antibodies to explore retinoic acid signaling pathways and their effects on cellular processes. Advanced detection methods using horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates enable precise visualization of CYP26A1 expression patterns. Investigating CYP26A1's role in development and disease can lead to enhanced understanding of therapeutic approaches. Santa Cruz Biotechnology's CYP26A1 monoclonal antibodies support researchers worldwide in advancing scientific knowledge of retinoic acid metabolism and its impact on human health.